VACCELERATE is inviting you to participate in a digital symposium on observational studies that have assessed the effectiveness of vaccination against infection and severity of disease by the different variants of concern.
Four speakers will present their results: Nick Andrews (UK Health Security Agency, London, UK): COVID-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
Fredrik Kahn (Lund University, Lund, SE): Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities – surveillance results from southern Sweden, July 2021 to January 2022
Frederik Plesner Lyngse (University of Copenhagen, Copenhagen, DK): Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households
Laith Jamal Abu-Raddad (Weill Cornell Medicine-Qatar, Doha, Qatar): Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
VACCELERATE, the EU funded clinical research network for the coordination & conduct of COVID-19 vaccine trials is looking forward to hosting this webinar. The webinar will be recorded and published on https://vaccelerate.eu/.